Table 1.
Demographic and clinicopathological characteristics of the study population with PTC and HC.
| Characteristic | PTC n = 68 |
HC n = 86 |
p-Value |
|---|---|---|---|
| Gender | |||
| Male | 8 (11.8%) | 11 (12.79%) | |
| Female | 60 (88.2%) | 75 (87.2%) | |
| Age at initial surgery (years) | 48.19 (14.9) | 45.30 (12.07) | p = 0.221 |
| T (TNM), n (%) | - | - | |
| pT1a | 27 (39.7) | ||
| pT1b | 7 (10.3) | ||
| pT2 | 4 (5.9) | ||
| pT3a | 19 (27.9) | ||
| pT3b | 11 (16.2) | ||
| Tumor size (cm) | - | - | |
| ≤2 | 48 (70.6) | ||
| >2 | 20 (29.4) | ||
| Lymph node metastases at initial surgery | - | - | |
| Yes | 16 (23.5) | ||
| No | 52 (76.5) | ||
| Variant of PTC, n (%) | - | - | |
| The classical variant | 29 (42.6) | ||
| The follicular variant | 18 (26.5) | ||
| The diffuse sclerosing variant | 17 (25.0) | ||
| The tall cell carcinoma | 4 (5.9) | ||
| Extrathyroidal extension | - | - | |
| Yes | 30 (44.1) | ||
| No | 38 (55.9) | ||
| Lymphovascular invasion | - | - | |
| Yes | 36 (52.9) | ||
| No | 32 (47.1) | ||
| Multifocality | - | - | |
| Yes | 16 (23.5) | ||
| No | 52 (76.5) |